COVID-19 Update : ICMR Conformed BCG vaccine can prove effective in preventing coronavirus

Currently, scientists are constantly investigating the consequences of BCG vaccination on T cells, B cells, white blood corpuscle and dendritic cell immunity. aside from this, healthy elderly people, who are between 60-80 years aged , also are seriously examining their entire antibody level.

COVID-19 Update : ICMR Conformed BCG vaccine can prove effective in preventing coronavirus
ICMR Conformed BCG vaccine can prove effective in preventing coronavirus

The fight against the corona virus remains happening . In such a situation, ICMR has given a relief news. Scientists at ICMR have confirmed that the BCG vaccine wont to protect against tuberculosis may now prove effective against the corona virus. At an equivalent time, it are often seen more within the elderly. Currently, scientists are constantly investigating the consequences of BCG vaccination on T cells, B cells, white blood corpuscle and dendritic cell immunity. aside from this, healthy elderly people, who are between 60-80 years aged also are seriously examining their entire antibody level.

The BCG vaccine was launched 50 years ago, allow us to tell you that the corona virus is more susceptible to be fatal within the elderly who are quite 60 years old or affected by serious diseases like comorbidities. For information, allow us to know that the BCG vaccine is run to newborns under the Universal Immunization Program (UIP) of the Central Government. it had been launched 50 years ago. The Indian Council of Medical Research (ICMR) reported that in research, scientists at the institute found that the BCG vaccine induces memory cells responses and produces total antibodies within the elderly.

At an equivalent time, 86 people are included within the research thus far (July - September), during which 54 got vaccine and 32 weren't given. Also, all the vaccinated patients were also assessed one month after the vaccination. Reports have found that the median age within the BCG vaccination group was 65 years and people who weren't vaccinated had a median age of 63 years. Several clinical trials are still underway to determine the results of the BCG vaccine. Earlier research has shown that BCG vaccination in Indonesia, Japan and Europe has protected the elderly from respiratory diseases.

 

Last Updated :